publicações selecionadas
-
artigo académico
- RKIP overexpression reduces lung adenocarcinoma aggressiveness and sensitizes cells to EGFR-targeted therapies. Molecular Oncology. 2025
- Unveiling the RKIP and EGFR Inverse Relationship in Solid Tumors: A Case Study in Cervical Cancer. Cancers. 2024
- RKIP as an Inflammatory and Immune System Modulator: Implications in Cancer. Biomolecules. 2019
- Current Status of Raf Kinase Inhibitor Protein (RKIP) in Lung Cancer: Behind RTK Signaling. Cells. 2019
-
capítulo de livro
- Chapter 20 - Implications of RKIP protein in cancer prognosis and therapy response: A literature update 2020
- Angiogenesis and Chromene-based Antiangiogenic Therapeutic Agents 2020
- Implications of RKIP protein in cancer prognosis and therapy response: A literature update 2020
- Angiogenesis and chromene-based antiangiogenic therapeutic agents 2019
-
documento
- Role of RKIP protein in the modulation of cancer cells metabolism in solid tumors 2019
- RKIP protein as a potential prognostic, aggressiveness and therapy response biomarker in HNSCC 2019
- RKIP protein as a novel predictor of EGFR targeted therapies in lung cancer 2019
- RKIP protein induces HER receptors activation and positively modulate its pharmacological targeting in cervical cancer 2019
- RKIP protein as a novel predictor of EGFR targeted therapies in lung cancer 2018
- RKIP protein induces HER receptors activation and positively modulate its pharmacological targeting in cervical cancer 2018
- The biological role of RKIP in head and neck cancer: an in vivo and in vitro study 2018
- RKIP protein as a novel predictor of EGFR targeted therapies in Lung Cancer. 2018